• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Parnax Lab Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 2018.0
  • ISIN : INE383L01019
124.50 -1 (-0.40%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    122.55

  • Today’s High

    126.90

  • Open

    126.90

  • Perv Close

    125.00

  • 52W Low

    81.00

  • 52W High

    193.50

Key Indicators

  • P/E(TTM)

    102.89

  • Mar.Cap (₹Cr.)

    143.00

  • Div & Yield %

    0.00

  • Book Value(₹)

    19.63

  • Debt-Equity Ratio

    -0.40

  • AGM Date

    01-Aug-2025

  • EPS

    1.21

  • P/E Ratio

    102.89

Financials Ratios

  • Debt-Equity Ratio

    1.01

  • Mar.Cap (₹Cr.)

    143.00

  • RONW (%)

    14.39

  • ROCE (%)

    12.87

Score Board

  • Equity (₹ in Cr.)

    11.49

  • BV (₹)

    19.60

  • Sales( ₹ in Cr.)

    7.02

  • NP (in Cr.)

    1.39

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    1.30

  • EPS (₹)

    1.20

  • Traded Value (₹ in Lakhs)

    143.00

  • 52 Week High

    193.50

  • 52 Week Low

    81.00

  • Price BSE

    125.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    143.00

  • P/C Ratio

    98.50

  • P/E Ratio

    102.90

  • Price Vs.BV

    1.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 7.44 7.47 7.15 2.37 7.68 6.49
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7.44 7.47 7.15 2.37 7.68 6.49
Other Income 0.54 0.37 0.16 0.07 0.42 0.51
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 7.98 7.84 7.31 2.44 8.10 7.00
EXPENDITURE :            
Raw Materials 3.01 3.48 3.40 1.46 4.31 3.21
Power and Fuel Cost 0.02 0.02 0.11 0.14 0.15 0.16
Employee Cost 0.74 0.55 0.52 0.45 0.51 0.45
Other Manufacturing Expenses 1.01 1.12 1.08 0.30 0.61 0.68
Selling and Administration Expenses 0.55 0.59 0.47 0.35 0.58 0.56
Miscellaneous Expenses 0.01 0.15 0.20 0.12 0.97 1.33
Employee Benefit Expenses 0.74 0.55 0.52 0.45 0.51 0.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5.33 5.90 5.78 2.82 7.14 6.39
Operating Profit 2.65 1.94 1.53 -0.38 0.95 0.62
Interest 0.14 0.25 0.71 0.83 1.38 1.08
Gross Profit 2.51 1.69 0.82 -1.21 -0.43 -0.46
Depreciation 0.06 0.07 0.04 0.04 0.04 0.05
Profit Before Tax 2.45 1.62 0.78 -1.25 -0.47 -0.51
Current Tax 0.00 0.00 0.00 0.13 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.62 0.42 0.24 -0.25 1.53 0.32
Reported Net Profit 1.82 1.20 0.54 -1.13 -2.00 -0.83
Extraordinary Items 0.00 0.00 0.00 0.00 0.01 0.00
Adjusted Net Profit 1.82 1.20 0.54 -1.13 -2.01 -0.83
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -8.49 -9.69 -10.23 -9.10 -7.10 -6.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -6.66 -8.49 -9.69 -10.23 -9.10 -7.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.59 1.05 0.55 -1.33 -2.36 0.00
Earnings Per Share(Adj)-Unit Curr 1.59 1.05 0.55 -1.33 -2.36 0.00
Book Value 18.42 16.85 11.14 5.54 6.85 9.20
Book Value(Adj)-Unit Curr 18.42 16.85 11.14 5.54 6.85 9.20

Shareholding Pattern

  • Promoter Group

    72.30%

  • Public Share Holding

    27.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,303,766 72.30 8,303,766 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,303,766 72.30 8,303,766 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 35,277 0.31 32,127 23
Clearing Members 3,100 0.03 3,100 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 113,375 0.99 113,375 71
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 162,332 1.41 162,332 109
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,219,040 10.61 1,219,040 26
Individuals holding nominal share capital up to Rs. 1 lakh 1,648,544 14.35 1,607,744 4,077
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,181,850 27.70 3,137,900 4,310
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,485,616 100.00 11,441,666 4,317

Company Background

Parnax Lab LtdPharmaceuticals - Indian - Formulations

  • Parnax Lab Ltd
  • BSE Code : 2018.0
  • ISIN : INE383L01019

  • Incorporation Year

    1982

  • Registered Office

    Gala 114 Bldg No 8
    Jogani Ind Complex Chunabhatti, Mumbai,
    Maharashtra-400022

  • Telephone

    91-022-6825 2525

  • FAX

    91-022-2405 7728

  • Chairman

  • Managing Director

    Binoy Baiju Shah

  • Company Secretary

  • Auditor

    C N Patel & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Parnax Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Parnax Lab 124.50 7.98 7.44 102.89 9.09
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10